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There are two separate but interrelated initiatives that are especially threatening to the NIH: consolidation (also referred to as centralization) and outsourcing (or privatization). Federal directives that have begun implementing these policy changes are already having negative effects on NIH activities that should be cause for alarm within the scientific community.
In 2003, the Office of Management and Budget issued a revised version of its Circular A-76. Based on requirements of the Federal Activities Inventory Reform Act of 1998 ("FAIR Act"), all federal agencies, including the NIH, must categorize their activities as either "inherently governmental" (that is, "so intimately related to the public interest as to mandate performance by government personnel") or "commercial" (functions that "could be performed by the private sector"). 2 The objective, "to ensure that the American people receive maximum value for their tax dollars," will be achieved both by "competitive sourcing" (the requirement that federal agencies must compete with commercial vendors for functions designated as commercial 3 ) and by reducing the overall size of the workforce (also a goal of consolidation policies).
The NIH has already begun determining which positions and functions should be classified as governmental and which as commercial. By September 30, 2004, the NIH must complete comparative cost studies on 2300 positions (about 13% of the workforce) that include personnel involved in grant evaluation, funding, and implementation. Two outsourcing competitions have already been announced and opened for bids. 4 One of these is to "provide all management, supervision, administration, and labor to support the Grants Management, Program Support, and Review Support services," but this year, it will be limited to technical support personnel who assist the professional grant management staff. The other is "to provide property management services in existing buildings, animal facilities, laboratories and support facilities located on the NIH Campus," but only real estate property managers are targeted this year. At this time, no scientific or senior administrative positions are slated for competition, but no assurance has been offered that they would not be privatized in the future.
There are at least two major concerns related to outsourcing. First, when functions are shifted to the private sector, services will almost certainly be performed and decisions made by nongovernment individuals without direct experience and knowledge of the NIH. Conflicts of interest, including pressures imposed on the privatized groups by political, economic, and other professional sources, will be difficult, if not impossible, to monitor sufficiently to guarantee independence and impartiality. The competitive process might preferentially select for business or finance experience rather than skills more appropriate to running a scientific research enterprise, because contracts will be awarded based on fixed price and performance. Furthermore, personnel turnover could be high, as contracts will be for fixed periods (the current competition for extramural-activities support specifies a performance period of 12 months with options for additional 12-month periods). As a result, there will likely be erosion in the level of knowledge and insight currently available in-house. In our view, this is not a responsible approach to stewardship of a $27 billion agency. Second, the financial savings anticipated will not be achieved, at least in the short run. Secretary of Health and Human Services Tommy Thompson has promised that no jobs will be lost because of the outsourcing regulations, and this assurance was provided specifically to NIH employees in a memorandum dated September 27, 2002, from Dr. Charles E. Leasure Jr., deputy director of management at the NIH.
5 Thus, to the extent that NIH competes unsuccessfully for functions opened to competitive bid, it will have to pay both outside contractors and the displaced employees. According to NIH Associate Director for Budget Don Poppke, additional costs due to outsourcing, which could be as high as $157 million, may have to come from FY 2004 research funds. 6 Centralizing operations is also troublesome and a further blow to NIH morale. As part of the "President's Management Agenda," Secretary Thompson has committed the Department of Health and Human Services (HHS) to speak with "one voice" as "one Department." 7 The NIH, like other administrative units in HHS, has been directed to transfer administrative functions such as personnel issues (hiring, promotion, and retention), approval of expenditures and space allocations, and other management activities to the central office. HHS also plans to assume control of NIH press offices and congressional relations, but, so far, Congress has prevented it from doing so by language inserted into the HHS appropriation bill. Last year, the department began requiring NIH to include the HHS logo on all official documents, 8 and earlier this year, NIH supervisors were asked to sign a pledge indicating their support for the "One HHS" agenda. 9 As part of the consolidation initiative, HHS is aiming for a department-wide 15% reduction in administrative management and support positions by the end of FY 2004.
The negative impact of consolidation is already evident at the NIH. Placing personnel decisions in the NIH central office, a transitional step toward HHS assuming control in October, has removed institute managers from playing appropriate roles in hiring and promoting staff members. Institutes can no longer give bonuses directly, and they now have only a very limited role in certifying applicants' qualifications and identifying "best" candidates. When such decisions are made at HHS, the situation will only be that much worse. Consider, for example, that at HHS the director for human resources is responsible for the Center for Medicare and Medicaid Services and the Food and Drug Administration, in addition now to the NIH. Hiring will likely involve a commercial vendor. Basic management processes will become even more inefficient and unresponsive. NIH could even lose the ability to determine hiring priorities, which could create a mismatch between research goals set by the NIH and those of HHS. Similarly, if procurement decisions are made at HHS, the expertise necessary to obtain the highly specialized equipment and supplies required by intramural researchers cannot be guaranteed. The worst-case scenario envisions a central budget office and centralized grants management offices located in HHS.
NIH Director Elias Zerhouni met with Secretary Thompson on June 27, 2003 to discuss these concerns and offer an alternative proposal that would meet HHS objectives for efficient management while recognizing NIH's unique status. Although a compromise plan "to preserve the independence of managing science" was not immediately forthcoming, the secretary has not yet given a formal answer to the NIH request. 8 Achievements in biomedical science are among America's greatest contributions to the world. Although not without flaws, the NIH and its many dedicated scientists and administrators who work within and for the system have been major components in the success of this enterprise. 10 To tinker with the system for poorly justified reasons of cost and efficiency based on political philosophy is, we believe, ill advised. Changes of the type that the Office of Management and Budget is recommending threaten the quality and integrity of the scientific enterprise in the United States. Moreover, they could serve as an unfortunate model for privatization in other countries. The neurological scientific community needs to become sensitized to this vital issue and make its feelings known to Congress and the administration.
